A new 2025 study from the European Journal of Preventive Cardiology reveals that a simple physical test—how quickly you can stand up from a chair—is one of the strongest predictors of whether you’ll survive the next decade. Adults aged 46 to 75 who scored lowest on the sit-to-stand test faced a 42% mortality rate over 10 years, compared to just 3.7% for those with the highest scores. That’s a difference of 97% survival versus 73%, based on real data from 4,282 people followed for an average of 12 years. The research establishes sit-to-stand performance as a surprisingly accurate window into long-term health—one that researchers believe deserves serious attention alongside traditional risk factors. However, the widely circulated claim that sit-to-stand “predicts mortality better than cholesterol” doesn’t appear in published peer-reviewed studies comparing the two directly. The recent research powerfully demonstrates sit-to-stand’s predictive value, but it doesn’t include a head-to-head measurement against cholesterol levels.
This distinction matters because it separates what we know for certain from what remains to be studied. What is certain: how easily your body can move holds clues about your future health that standard medical checkups may miss entirely. For older adults, caregivers, and families managing aging in place, this finding offers something more useful than statistics—it offers a practical, free assessment you can perform at home right now. No equipment needed. No blood work. Just you, a sturdy chair, and 30 seconds.
Table of Contents
- Why Can a Chair Test Predict 10-Year Survival Better Than Most People Expect?
- What the Mortality Numbers Actually Mean—And What They Don’t
- The Real-World Meaning of Sit-to-Stand Performance for Aging in Place
- How This Test Compares to Cholesterol and Other Risk Factors
- The Biggest Limitation—Sit-to-Stand Doesn’t Prevent Mortality; It Predicts It
- How to Perform and Score the Sit-to-Stand Test at Home
- What’s Next—Using the Sit-to-Stand Test as a Tool for Proactive Aging
- Conclusion
Why Can a Chair Test Predict 10-Year Survival Better Than Most People Expect?
The sit-to-stand test measures muscle strength, balance, and functional mobility all at once—three things that decline as we age but that directly determine whether you can stay independent. When researchers followed 4,282 adults and scored them 0 to 10 based on how many times they could stand up and sit down in 30 seconds, the results aligned with mortality outcomes more strongly than most fitness measures. Those scoring 10 completed roughly 14 stand-ups; those scoring 0 managed fewer than 5. The gap isn’t just about fitness—it reflects bone density, neurological control, cardiovascular conditioning, and muscle quality working together. Think of it this way: a person who can’t easily rise from a chair is also likely struggling with falls, walking downstairs safely, getting out of bed, reaching kitchen shelves, or pushing away from a table.
All of those limitations increase risk. When muscles weaken below a certain threshold, the body becomes vulnerable to everything from pneumonia to fractures. A 50-year-old who performs like a 75-year-old on this test is statistically at higher risk of dying in the next decade than age-matched peers who move easily. The study followed people for a median of 12.3 years, recording 665 deaths among the 4,282 participants. That’s real mortality data, not modeled or predicted—people who took the test and then were tracked until death or study end. The differences were stark: lowest-scoring participants had 3.8 times higher risk of natural death and 6 times higher risk of cardiovascular death than the highest scorers.
What the Mortality Numbers Actually Mean—And What They Don’t
Breaking down the numbers: those with a score of 10 had a 3.7% chance of dying within 10 years (97% survival); those scoring 8 faced 7–11% mortality; and those scoring 0 to 4 faced a 42% mortality rate (73% survival). These are compelling patterns, but they’re also averages across a population—your personal outcome depends on your age, other health conditions, genetics, lifestyle, and access to medical care. The limitation worth noting: the study population was 68% men, median age around 65, mostly European, and able to participate in the study itself (which excludes people too ill to attend). So if you’re older, female, or managing multiple chronic illnesses, your individual risk may differ. Additionally, the sit-to-stand score captures current physical ability but doesn’t explain why two people with the same score might have different outcomes.
One person might be strong but have early-stage heart disease; another might be naturally flexible but lack cardiovascular fitness. The test is a marker, not a diagnosis. A critical downside: this test doesn’t replace medical checkups, blood pressure monitoring, or cholesterol screening. It complements them. Someone can pass a sit-to-stand test with flying colors and still have undetected high blood pressure or diabetes. The value is in catching functional decline early—because once muscles weaken past a certain point, reversing it becomes much harder.
The Real-World Meaning of Sit-to-Stand Performance for Aging in Place
For someone 65 or older aiming to age safely at home, sit-to-stand ability directly predicts independence. A person who can rise easily from a chair can get out of bed without calling for help, transfer safely from a toilet, pull themselves up if they fall, and maintain the strength to catch themselves. A person who can’t often becomes a fall risk, loses confidence moving through their home, and may need a caregiver nearby at all times. This isn’t abstract. Consider a 72-year-old woman living alone who wants to stay in her home. Her doctor says she’s healthy—normal blood pressure, no diabetes diagnosis, nothing flagged in blood work. But she can only stand up and sit down 7 times in 30 seconds (a score of 6 or 7).
That puts her in the moderate-risk category, with roughly an 11–20% mortality risk over 10 years. More immediately, it means she’s vulnerable to falls when getting out of the bathtub, at risk of a fracture if she trips on a stair, and losing the strength she’ll need if she gets pneumonia and has to recover at home. A targeted strength program—even 2–3 months of bodyweight exercises—could shift her score by 2–3 points and meaningfully reduce her real-world risks. The sit-to-stand test is also a baseline measure. If you test yourself now at age 60 or 65, you know what your baseline looks like. Testing again in 1–2 years shows whether you’re maintaining strength or declining. Unexpected decline might signal an underlying issue (medication side effect, depression, thyroid disease) worth investigating.
How This Test Compares to Cholesterol and Other Risk Factors
The claim in popular headlines—that sit-to-stand “beats cholesterol” as a predictor—hasn’t been proven in direct comparison studies that measure both simultaneously. Cholesterol remains a validated risk factor for heart disease, and doctors don’t check it for no reason. What researchers are saying instead is that sit-to-stand performance is such a powerful marker that it rivals or complements traditional laboratory measures. It’s not an either-or situation; it’s an addition to standard screening. The advantage of sit-to-stand over cholesterol is practical simplicity. You need no equipment, no doctor’s visit, no lab draw, no fasting, no insurance approval.
A caregiver can administer it at home. The downside is that sit-to-stand is subjective—different people might interpret “sit down fully” or “count faster or slower” differently—whereas cholesterol is a number. Also, cholesterol levels indicate specific metabolic issues that doctors can treat with statins or dietary changes. A low sit-to-stand score tells you there’s a problem but requires more investigation to find what’s causing it: muscle disease, nerve damage, heart disease, deconditioning, arthritis, or medication side effects. For aging in place, the practical approach is simple: use both. Know your cholesterol and other standard markers, but also test your sit-to-stand regularly. If the score is dropping, ask your doctor why and explore whether strength training, nutrition changes, or medication adjustments might help.
The Biggest Limitation—Sit-to-Stand Doesn’t Prevent Mortality; It Predicts It
Here’s the critical caveat: knowing you have a low sit-to-stand score doesn’t automatically give you treatment options, the way diagnosing high cholesterol or diabetes does. A doctor can prescribe a statin for cholesterol or metformin for blood sugar. For a low sit-to-stand score, the response is less definitive—it usually means “start exercising” and “strengthen your muscles”—which is good advice but harder to execute, especially for someone already deconditioned or suffering from chronic pain. The other limitation: many people with low sit-to-stand scores already know they’re struggling. They can feel they’re weak; they don’t need a test to tell them.
The value of the test is for people who feel “fine” but are actually in decline—the 60-year-old who passes a routine doctor visit but is slowly losing muscle. Those are the people most likely to benefit from early intervention. Finally, a warning: the sit-to-stand test shouldn’t be used to stigmatize or fatally discourage older adults. Someone who scores low isn’t doomed. The 42% mortality rate for low scorers over 10 years means 58% survived. Many people with low scores lived a full decade and beyond with the right support, care, and sometimes targeted rehabilitation.
How to Perform and Score the Sit-to-Stand Test at Home
The test is straightforward: sit in a firm chair with your back against the back of the chair and feet flat on the floor. On a timer, stand fully upright (without using your hands) and return to sitting, repeating as many times as possible in 30 seconds. Count each complete stand-sit cycle.
Most studies score results from 0 to 10 based on age and gender, though the simple count itself (how many repetitions) is often more useful for individuals tracking change over time. For example, a 65-year-old woman completing 8 repetitions in 30 seconds is likely in the 6–7 score range—solidly in the moderate risk category. Doing the test monthly or quarterly and watching that number climb (if you’re training) or decline (if you’re sedentary) gives real-time feedback on functional status. If the count drops by 30% over a few months without injury, that’s a sign to see a doctor.
What’s Next—Using the Sit-to-Stand Test as a Tool for Proactive Aging
The European research is recent (2025) and likely to reshape how doctors and rehabilitation specialists screen for hidden health risks in middle-aged and older adults. Expect to see the sit-to-stand test incorporated into routine geriatric assessments, balance screening, and cardiac rehabilitation programs. For now, it remains underutilized in primary care, even though it’s free and requires nothing but 30 seconds.
For individuals and families, the takeaway is to start thinking of functional ability—not just laboratory numbers—as a health marker worth monitoring. If you’re over 60, perform the test yourself, note the number, and aim to maintain or improve it with strength training, walking, or balance work. If you’re a caregiver for an older adult, this test gives you an objective way to track whether their mobility is stable or declining. The chair test won’t replace your doctor, but it offers an honest reflection of how well your body is equipped to face the next decade.
Conclusion
A 2025 study tracking nearly 4,300 adults over 12 years found that performance on a simple sit-to-stand test—how many times you can rise from a chair in 30 seconds—is one of the most accurate predictors of 10-year mortality available. Adults with the lowest scores faced 42% mortality over a decade, while those with the highest scores faced just 3.7%. The gap reflects more than fitness; it captures whether your muscles, balance, cardiovascular system, and nervous system are equipped to maintain independence and survive health challenges. The research doesn’t replace traditional risk screening like cholesterol checks, and the popular claim that sit-to-stand “beats cholesterol” as a predictor hasn’t been proven in direct studies. What is proven is that this free, equipment-free test reveals functional decline that laboratory work might miss—and that decline is deeply linked to survival.
For anyone aging in place, managing a family member’s care, or simply curious about their own trajectory, the sit-to-stand test offers a straightforward, actionable baseline. Test yourself today. Repeat it in a few months. If the score is dropping, talk to your doctor. If it’s stable or rising, you’re building the strength that aging in place demands.